Isodiol International Inc (ISOLF)

[lithiumjr]

Isodiol International Inc. Announces Distribution Agreement for South America

https://www.centralcharts.com/en/news/930907-isodiol-international-inc-announces-distribution-agreement-for-south-america

VANCOUVER, British Columbia, Aug. 30, 2017 (GLOBE NEWSWIRE) -- Isodiol International Inc. (CSE:ISOL) (OTC:LAGBF) (FSE:LB6A.F) (the “Company” or “Isodiol”) a global cannabinoid innovator specializing in the development of pharmaceutical and consumer products announces it has signed a distribution partnership with FarmaUSA™, a leading global wholesale distributor of imported pharmaceutical products in South America. This is the latest action taken by the Company to further secure its position in the Brazilian market and provide for an additional expansion into greater South America.

This deal will expand Isodiol's product Isoderm™ in Brazil and across South America by utilizing FarmaUSA's existing distribution and doctor network to increase the presence of Isoderm™ Direct Effect Technologies™. FarmaUSA will facilitate physician conferences across the country to further educate healthcare professionals on the benefits of Isoderm™ while continuing to work with regulatory officials at Agência Nacional de Vigilância Sanitária (ANVISA) for commencing a clinical trial.

Marcos Agramont, CEO of Isodiol International Inc. stated, “This is a major milestone in the development of our international expansion strategy. FarmaUSA is very well respected among healthcare professionals in South America to help facilitate this process for the Company. I anticipate a dramatic increase in the amount of prescriptions being written by physicians in these markets as we move forward and head towards a clinical trial in the coming months.”

Djalma Nogueria, CEO of FarmaUSA stated, “We are very excited to work with Isodiol in bringing Isoderm™ to the South American market. We have seen a tremendous initial response from the health professionals who have commenced prescribing the product and we anticipate this to continue. With our Isodiol partnership now established, we are well positioned to enter additional markets in South America and become the leader in the space.”

About Isodiol International Inc.

Isodiol International Inc. is the market leader in pharmaceutical and nutraceutical grade phytochemical compounds and the industry leader in the manufacturing and development of phytoceutical consumer products.

Isodiol is the pioneer of many firsts for the cannabis industry including commercialization of a 99%+ pure pharmaceutical grade cannabinoid crystalline isolate derived from exempt parts of the hemp plant, micro-encapsulations, and nanotechnology for the highest quality consumable and topical skin care products.

Isodiol's growth strategy includes the development of over-the-counter and pharmaceutical drugs, expanding its phytoceutical portfolio and will aggressively continue International expansion into Latin America, Asia and Europe.